88 related articles for article (PubMed ID: 38702897)
1. Neuronal surface antibody-mediated autoimmune encephalitis.
Linnoila JJ; Rosenfeld MR; Dalmau J
Semin Neurol; 2014 Sep; 34(4):458-66. PubMed ID: 25369441
[TBL] [Abstract][Full Text] [Related]
2. General features, pathogenesis, and laboratory diagnostics of autoimmune encephalitis.
Masciocchi S; Businaro P; Scaranzin S; Morandi C; Franciotta D; Gastaldi M
Crit Rev Clin Lab Sci; 2024 Jan; 61(1):45-69. PubMed ID: 37777038
[TBL] [Abstract][Full Text] [Related]
3. Genetic predisposition to autoimmune encephalitis and paraneoplastic neurological syndromes.
Muñiz-Castrillo S; Honnorat J
Curr Opin Neurol; 2024 Jun; 37(3):329-337. PubMed ID: 38483154
[TBL] [Abstract][Full Text] [Related]
4. [Clinical Phenomenology of Autoimmune Encephalitis].
Holle JF; Jessen F; Kuhn J
Fortschr Neurol Psychiatr; 2016 May; 84(5):271-80. PubMed ID: 27299786
[TBL] [Abstract][Full Text] [Related]
5. Antibody-positive autoimmune encephalitis and paraneoplastic neurological syndrome: A Swedish case series.
Kosek S; Burman J; Punga AR
Brain Behav; 2024 May; 14(5):e3534. PubMed ID: 38702897
[TBL] [Abstract][Full Text] [Related]
6. [Paraneoplastic neurologic syndromes: laboratory diagnostics and immunological aspects].
Hayden Z; Böröcz K; Csizmadia Z; Kellermayer Z; Balogh P; Berki T
Magy Onkol; 2019 Sep; 63(3):261-267. PubMed ID: 31533147
[TBL] [Abstract][Full Text] [Related]
7. Paraneoplastic Neurological Syndromes and Glutamic Acid Decarboxylase Antibodies.
Ariño H; Höftberger R; Gresa-Arribas N; Martínez-Hernández E; Armangue T; Kruer MC; Arpa J; Domingo J; Rojc B; Bataller L; Saiz A; Dalmau J; Graus F
JAMA Neurol; 2015 Aug; 72(8):874-81. PubMed ID: 26099072
[TBL] [Abstract][Full Text] [Related]
8. N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes.
Irani SR; Bera K; Waters P; Zuliani L; Maxwell S; Zandi MS; Friese MA; Galea I; Kullmann DM; Beeson D; Lang B; Bien CG; Vincent A
Brain; 2010 Jun; 133(Pt 6):1655-67. PubMed ID: 20511282
[TBL] [Abstract][Full Text] [Related]
9. Rituximab Treatment and Long-term Outcome of Patients With Autoimmune Encephalitis: Real-world Evidence From the GENERATE Registry.
Thaler FS; Zimmermann L; Kammermeier S; Strippel C; Ringelstein M; Kraft A; Sühs KW; Wickel J; Geis C; Markewitz R; Urbanek C; Sommer C; Doppler K; Penner L; Lewerenz J; Rößling R; Finke C; Prüss H; Melzer N; Wandinger KP; Leypoldt F; Kümpfel T;
Neurol Neuroimmunol Neuroinflamm; 2021 Nov; 8(6):. PubMed ID: 34599001
[TBL] [Abstract][Full Text] [Related]
10. Seasonal variation in autoimmune encephalitis: A multi-center retrospective study.
Lai QL; Cai MT; Zheng Y; Zhang TY; Fang GL; Shen CH; Qiao S; Zhang YX
J Neuroimmunol; 2021 Oct; 359():577673. PubMed ID: 34333343
[TBL] [Abstract][Full Text] [Related]
11. Spatial and Ecological Factors Modulate the Incidence of Anti-NMDAR Encephalitis-A Systematic Review.
Alentorn A; Berzero G; Alexopoulos H; Tzartos J; Reyes Botero G; Morales Martínez A; Muñiz-Castrillo S; Vogrig A; Joubert B; García Jiménez FA; Cabrera D; Tobon JV; Delgado C; Sandoval P; Troncoso M; Galleguillos L; Giry M; Benazra M; Hernández Verdin I; Dade M; Picard G; Rogemond V; Weiss N; Dalakas MC; Boëlle PY; Delattre JY; Honnorat J; Psimaras D
Biomedicines; 2023 May; 11(6):. PubMed ID: 37371620
[TBL] [Abstract][Full Text] [Related]
12. Glutamic acid decarboxylase antibody-associated neurological syndromes: Clinical and antibody characteristics and therapy response.
Madlener M; Strippel C; Thaler FS; Doppler K; Wandinger KP; Lewerenz J; Ringelstein M; Roessling R; Menge T; Wickel J; Kellingshaus C; Mues S; Kraft A; Linsa A; Tauber SC; Berg FT; Gerner ST; Paliantonis A; Finke A; Priller J; Schirotzek I; Süße M; Sühs KW; Urbanek C; Senel M; Sommer C; Kuempfel T; Pruess H; Fink GR; Leypoldt F; Melzer N; Malter MP;
J Neurol Sci; 2023 Feb; 445():120540. PubMed ID: 36608627
[TBL] [Abstract][Full Text] [Related]
13. Encephalitis in adults in the Auckland and Northland regions of New Zealand, 2009 to 2018.
Liem B; Anderson NE; Wright SL; Anderson SC; Donnelly J; Austin P; Steele R
J Clin Neurosci; 2023 Jan; 107():172-177. PubMed ID: 36494269
[TBL] [Abstract][Full Text] [Related]
14. Clinical, serological and genetic predictors of response to immunotherapy in anti-IgLON5 disease.
Grüter T; Möllers FE; Tietz A; Dargvainiene J; Melzer N; Heidbreder A; Strippel C; Kraft A; Höftberger R; Schöberl F; Thaler FS; Wickel J; Chung HY; Seifert F; Tschernatsch M; Nagel M; Lewerenz J; Jarius S; Wildemann BC; de Azevedo L; Heidenreich F; Heusgen R; Hofstadt-van Oy U; Linsa A; Maaß JJ; Menge T; Ringelstein M; Pedrosa DJ; Schill J; Seifert-Held T; Seitz C; Tonner S; Urbanek C; Zittel S; Markewitz R; Korporal-Kuhnke M; Schmitter T; Finke C; Brüggemann N; Bien CI; Kleiter I; Gold R; Wandinger KP; Kuhlenbäumer G; Leypoldt F; Ayzenberg I;
Brain; 2023 Feb; 146(2):600-611. PubMed ID: 35259208
[TBL] [Abstract][Full Text] [Related]
15. Anti-NMDAR Encephalitis in the Netherlands, Focusing on Late-Onset Patients and Antibody Test Accuracy.
Bastiaansen AEM; de Bruijn MAAM; Schuller SL; Martinez-Hernandez E; Brenner J; Paunovic M; Crijnen YS; Mulder MJHL; Schreurs MWJ; de Graaff E; Smitt PAE; Neuteboom RF; de Vries JM; Titulaer MJ
Neurol Neuroimmunol Neuroinflamm; 2022 Mar; 9(2):. PubMed ID: 34937737
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
